Innovative Vector Control Consortium

Registered charity 1128437 · since 2009ivcc.com·International·Updated 31 October 2026

At a glance

£2M

Annual giving, year to 31 July 2025

From filed accounts

Open to applications

Rolling, no deadlines · unsolicited applications welcome

Key takeaways

Its stated focus is vector-control product development, especially tools aimed at eliminating malaria in resource-poor markets, so a charity whose work sits well outside that field is unlikely to fit.
The stated geographic focus is any part of the world, and no grant range is given, though the annual report shows £2,013,000 paid in total, so tie any request to a specific product development project.
Applications are accepted on a rolling basis: start with an outline proposal, which the External Scientific Advisory Committee reviews for portfolio fit and likely success, and only then prepare the fuller scientific and budgetary application, showing a credible regulatory pathway and effect on vector-borne disease transmission.
Do not apply if your project involves genetically modified mosquitoes, Wolbachia or other endosymbiotic organisms, endectocides targeting humans, a political element, or academic research informing product development, unless that research answers a specific IVCC call.
Have ready your complete governing documents, your company or charity number if you have one, and evidence of a bank account with at least two unrelated signatories.

Overview

Innovative Vector Control Consortium is a charity registered with the Charity Commission for England and Wales (charity number 1128437).

Innovative Vector Control Consortium is a registered charity whose stated purpose is the preservation and protection of good health and the relief of sickness by alleviating and preventing the spread of any type of tropical disease. It operates as a Product Development Partnership, bridging the gap between industry, academia and public health to speed up the development of innovative vector control tools. The annual report shows £2,013,000 paid out in its latest financial year.

What they fund

Priority Areas

IVCC supports the development of vector-control tools and their market uptake, especially product development targeted at eliminating malaria through vector control in resource-poor markets. Its subaward priorities include novel active ingredients with new modes of action for existing products, proof-of-concept projects for novel vector-control products, and innovations that add measurable value to existing malaria interventions. It welcomes proposals from organisations with relevant expertise, access to technology with vector-control potential, and the ability to bring products to the public-health market. Proposals are assessed for portfolio fit and likely success by an External Scientific Advisory Committee, with successful outlines proceeding to full scientific and budgetary review. IVCC works with industry, research institutions, funders and public-health partners.

Themes

Vector control product development

Geographic Focus

Any Part Of The World.

What they don't fund

Subaward only:
- Projects relating to genetically modified mosquitoes
- Endosymbiotic organisms such as Wolbachia
- Endectocides targeting humans
- Projects with a political element
- Academic research projects informing product development, unless they are in response to a specific call for proposals from IVCC and required to answer specific product development questions

How to apply

Applicants submit outline proposals for review by the External Scientific Advisory Committee, which assesses portfolio fit and likely success. After a successful initial review, they submit a more detailed application for full scientific and budgetary review before implementation.

Who can apply:

Subawards: IVCC welcomes proposals that support IVCC Charitable Objectives and funding priorities from any organization demonstrating expertise, access to technology with potential for vector control and the ability to bring products to public health market.

What to send:

Subawards
- Complete, up to date copy of organisation’s governing documents
- Company/charity number (if applicable)
- Evidence of a bank account with at least two unrelated signatories.

Application success factors

What the charity says:

Applicants must demonstrate relevant expertise, access to technology with vector-control potential, and the ability to bring products to the public-health market.
Products should be effective in reducing vector-borne disease transmission and fit into disease-control programmes.
Products should have a credible regulatory pathway and meet regulatory safety criteria.

Where they fund

Where it says it funds

International

Similar funders

Funders supporting work similar to Innovative Vector Control Consortium.

Tres Cantos Open Lab FoundationRollingGave £1.3M Meningitis Research FoundationFixed deadlines 20th International Geographical Congress FundFixed deadlinesGave £3,500 Académie du Vin FoundationRollingGave £23,858 Action for A-TFixed deadlinesGave £116k Advance Movement UKInvitation only A. G. Leventis FoundationFixed deadlines Ahavas Chesed TrustNo public processGave £566k A J H Ashby Will TrustRolling Allan & Nesta Ferguson Charitable TrustRollingGave £1.8M

Five years of accounts

Financial year	Income	Expenditure	Grants paid	Accounts document
year to 31 July 2021	£39,438,000	£38,205,000	—	Accounts for year to 31 July 2021
year to 31 July 2022	£48,609,000	£47,474,000	—	Accounts for year to 31 July 2022
year to 31 July 2023	£33,436,000	£32,333,000	—	Accounts for year to 31 July 2023
year to 31 July 2024	£20,347,000	£20,189,000	—	Accounts for year to 31 July 2024
year to 31 July 2025	£19,097,000	£17,273,000	£2,013,000	Accounts for year to 31 July 2025

Grants paid, year to 31 July 2025: grants paid out in the year.

— No grants figure for those years.

Figures from the charity’s filed accounts and its register entry. The document icon links to the charity’s entry on the Charity Commission register, where its filed accounts can be found.